NOV 21, 2017 11:09 AM PST

Cancer Drugs with a Dual Purpose: Lowering Blood Pressure

WRITTEN BY: Kara Marker

A common ingredient in cancer drugs could also be used to treat hypertension, or high blood pressure. From Georgetown University Medical Center, researchers look deeper into fibroblast growth factor (FGF), its inhibitors, and how it influences both cancer growth and high blood pressure (hypertension).

Each patient is different, and while there are many drugs on the market designed to treat hypertension, a new class of drugs that works through a different mechanism could help patients who do not respond well to other drugs. Researchers think that FGF inhibitors may be the key to developing a new class of hypertension drugs.

Fibroblast growth factor (FGF) inhibitors work in cancer drugs by blocking angiogenesis, the creation of new blood vessels. Tumor cells use FGF to promote angiogenesis, and without it, cancer’s supply to blood is cut off. In this way, both FGF and FGF inhibitors influence blood pressure, and a protein called FGFBP1 (FGF Binding Protein 1) influences FGF.

"It's rare that a single class of drugs can be used for such different conditions, but that is what our study strongly suggests," explained senior investigator, Anton Wellstein, MD, PhD.

Inspired by a study that showed how a variation of the FGFBP1 gene could lead to overexpression of FGFBP1, increasing a person’s predisposition to developing hypertension, Wellstein and other researchers dived deeper into the link between FGFBP1 and hypertension in a mouse model. The model allowed them to turn FGFBP1 expression on or off. Blood pressure went from normal to unhealthy when researchers turned FGFBP1 expression on.

Researchers also found that FGF responds to a hormone called angiotensin II, which increases blood pressure by constricting blood vessels.

"FGF can control how sensitive the blood pressure regulation by angiotensin II is," Wellstein explained. "That tells us that if a person has hypertension, it is possible to target FGF signaling because it contributes to maintenance of high blood pressure by altering sensitivity to a major vasoconstrictive hormone, angiotensin II.”

With more research, FGF inhibitors could soon represent a new class of anti-hypertension drugs for people who do not respond well to existing drugs.

The present study was published in the journal Hypertension.

Source: Georgetown University Medical Center

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
DEC 15, 2019
Cardiology
DEC 15, 2019
Overuse Injuries And How To Avoid Them
It can be easy when first starting an exercise program to get carried away. Many newcomers believe that more means more. But it’s not just exercise, ...
DEC 15, 2019
Health & Medicine
DEC 15, 2019
What Are the Risks of Consuming Energy Drinks in Large Quantities in Young Healthy Individuals?
Energy drinks have large amounts of sugar, caffeine, and legal stimulants, including guarana, L-carnitine, and taurine that negatively impact the nervous s...
DEC 15, 2019
Cardiology
DEC 15, 2019
Workplace Wellness Programs Fall Short
Today, workplace wellness programs are offered by most large employers. They may be presented as part of an employee benefits package. These wellness progr...
DEC 15, 2019
Cardiology
DEC 15, 2019
Heart Conditions Amongst The Most Misdiagnosed
There are a massive number of diseases that a person can acquire. This can make the idea of diagnosing a disease accurately seem like a daunting task. Shoc...
DEC 15, 2019
Cardiology
DEC 15, 2019
Paleo Diet Alters Microbiome, May Harm Heart
New findings have raised concerns over the Paleolithic or Paleo diet. Recent research into the diet suggests that it lacks key nutritional components relat...
DEC 15, 2019
Cardiology
DEC 15, 2019
Heart Related Fatalities On The Rise
Recently published in JAMA, a new study sought to investigate national trends in deaths resulting from cardiometabolic disease. The study looked at cardiom...
Loading Comments...